Remove 2012 Remove DEA Remove Epilepsy
article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

Due to the Schedule I classification by the Drug Enforcement Agency (DEA), researchers seeking to investigate health effects associated with cannabis must follow a regimented application process. 33 Unintentional exposures to marijuana in children have increased each year since 2012, likely due to legalization policies across the U.S.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC. Lancet Neurol Dec 23 2015.

article thumbnail

What is THC? Here’s everything you need to know

The Cannigma

Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. in 2008, 12% in 2012 and 15% in 2018. It has shown potential for a variety of conditions and symptoms such as obesity, diabetes, epilepsy, Parkinson’s disease, anxiety and osteoporosis. THC in 1993, 8.8%

THC 98